Current practices around the use of oral chemotherapy in US cancer cen... Common malignancies can be treated with oral chemotherapy – a tre... Researchers from Boston set out to analyse the guidelines and pra...Most of the 42 organisations which took part in the study had no r...Nearly a quarter of the centres had no formal process for monitori...
Current practices around the use of oral chemotherapy in US cancer centres need to be improved, say doctors in a study on bmj.com.
Common malignancies can be treated with oral chemotherapy – a treatment// which is increasingly used across the USA and internationally.
Researchers from Boston set out to analyse the guidelines and practices used by comprehensive cancer centres for the provision of oral chemotherapy. Forty-two centres took part in the study. Variations in practice emerged in the prescribing methods, consent requests and the coordination and monitoring of treatment. They found that few of the safeguards which are routinely used for infusion chemotherapy were adopted for oral chemotherapy treatment.
Most of the 42 organisations which took part in the study had no required elements for prescribing oral chemotherapy and few requested patients’ written consent for off protocol prescribing. Only one in three organisations required a clinician to note the body surface area or calculation of dose on the prescription, and only one in four required the patients’ diagnosis or protocol.
Nearly a quarter of the centres had no formal process for monitoring patients’ adherence. In the past year respondents at 10 centres reported at least one serious adverse drug event related to oral chemotherapy and respondents at 13 centres reported a ‘serious near miss’.
The authors conclude that ‘prescribing, monitoring and coordination, pharmacy practices and education of patients for oral chemotherapy vary substantially. Despite clinicians’ concerns about oral chemotherapies, there is no apparent consensus among oncology professionals about safe practices for these drugs. The oncology community must define safe medication practices appropriate for oral chemotherapy, develop practice guidelines and accelerate their adoption.'
(Date:3/12/2010)... combines a focus on health and wellness and weight management ... , ... (Vocus) March 12, 2010 ... Natural Products Expo West today as part of the brand’s ... extension of the stage-one product portfolio, builds on the already ...
(Date:3/12/2010)... 1, 2010 new Medicare supplement (Medigap) plans M & N will ... never before seen with Medicare supplements. Precision Senior Marketing, a national ... for the new Medicare Supplement Plan N. , ... ... a national Medicare FMO, announced today that it is providing rates ...
(Date:3/12/2010)... ... , , ... ... ... A new grassroots campaign is expected to generate a million emails from constituents to their Congressional members, opposing ObamaCare. The One Million ...
(Date:3/12/2010)... of engineers from the CEIT-IK4 technological centre and doctors ... new tool for operating on the inner ear with ... auditory function during the surgery. This is the first ... implants, of which about a hundred are carried out ... new tool were four engineers from CEIT and five ...
(Date:3/12/2010)... ways to make your bedroom a place for ,rest and relaxation ... ... need sleep or how much sleep is recommended for optimal results. But ... decreased to the point where our health and well-being has been impaired. ... decreased productivity, drowsy driving and heart conditions. The people at ...
... Pistorius files appeal challenging International Association of Athletics Federation ... ... LONDON, Feb. 13 Oscar Pistorius -- a double amputee,athlete from ... today initiated an appeal before the Court of Arbitration for Sport,(CAS) ...
... 2008 The Elsevier Foundation has announced today that it ... institutions from around the world in support of initiatives that ... and medicine. The recipient programs were selected from over 150 ... the developing world and the academic workplace. , ...
... with glasses brought them up to snuff with ... News) -- Preschoolers with poor vision significantly improved ... wearing prescription glasses, a new study shows. , ... have early vision problems that are undiagnosed and ...
... a leading,provider of electronic payment solutions to the ... audit as a Payment Card,Industry (PCI) Level 1 ... are critical in an era when the Federal,Reserve ... 2/3rds,of all U.S. non-cash payments. The Payment Card ...
... ... - 85% Gross Profit ... Prior Year, CHICAGO, Feb. 13 The Female Health Company,(Amex: FHC ), which ... first quarter of,FY2008., For the three months ended December 31, 2007, the Company,s net,revenues ...
... for Continued Growth, CAMBRIDGE, Mass., Feb. 13 Genzyme Corporation,(Nasdaq: ... and,fourth quarter of 2007 and provided an outlook for continued strong ... revenue in 2007 increased 20 percent to $3.8 billion from $3.2 ... broadly driven by growth across all segments ...
(Date:3/11/2010)... -- With obesity in America reaching alarming levels -- across our adult and youth populations ... BodyMedia,s wearable body-monitoring technology either in conjunction with a group weight loss program or as ... more weight than individuals who attempted to battle the bulge solo. ... ... ...
(Date:3/11/2010)... The U.S. Food and Drug Administration ... drug application (sNDA) of a new six-month 45-mg ... Depot (leuprolide acetate for depot suspension) ... prostate cancer. Palliative treatment helps to relieve symptoms ... by suppressing the production of the hormone testosterone. ...
(Date:3/11/2010)... On March 10-11, 2010 , the Joint Advisory Committees ... and the Drug Safety and Risk Management Advisory Committees -- discussed the design ... SYMBICORT ® (budesonide/formoterol fumarate dihydrate). , ... ... ...
... SAN MATEO, Calif., June 10 /PRNewswire-FirstCall/ - NeurogesX, ... on developing and,commercializing novel pain management therapies, announced ... lead product candidate, NGX-4010, in the,journal Neurology. The ... Treatment of Painful HIV,Neuropathy," will appear in the ...
... a 24-week multi-center, randomized, open-label study presented ... ... Amylin Pharmaceuticals,Inc. (Nasdaq: AMLN ) today announced data showing ... therapy for 24,weeks resulted in more patients achieving diabetes treatment goals ...
... (GH) is a monomeric protein produced and ... gland. GH is released from the pituitary ... under the regulatory control of hypothalamic somatostatin ... timing and frequency of GH release appears ...
... Cortisol is the most potent ... cortex. In plasma, most cortisol is ... globulin (CBG), with the remainder loosely ... specific intracellular receptors with effects in ...
... factor I (IGF-I or somatomedin C) is a ... It acts as a potent mitogen of cellular ... cell-surface receptors. In the circulation, IGF-I is bound ... the actions of IGF-I by modulating the interaction ...
... (PSA) derives its name from its first ... The majority of PSA circulates bound ... Serum concentrations of PSA are elevated in ... (BPH) and prostatitis [1-3]. In addition, PSA ...